CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 810 enrolled
Drug / intervention
Fluticasone furoate/Vilanterol Inhalation Powder +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01147848
NCT01147848Phase 3Completed
CompareCT.gov

A Randomised, Double-blind, Double-dummy, Parallel-group Multicentre Study to Assess Efficacy and Safety of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Propionate/Salmeterol Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents

GlaxoSmithKline·interventional·Posted Jun 22, 2010·Updated Jan 18, 2017

In Brief

A Phase 3 clinical trial evaluating Fluticasone furoate/Vilanterol Inhalation Powder, Fluticasone propionate/salmeterol Inhalation Powder, and 2 other interventions for Asthma. Completed, enrolled 810 participants across 63 sites in 6 countries.

Detailed Summary

The purpose of the study is to compare the efficacy and safety of fluticasone furoate/vilanterol (GW642444) inhalation powder administered once daily with fluticasone propionate/salmeterol administered twice daily in adolescent and adult subjects 12 years of age and older with persistent bronchial asthma over a 24-week period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesArgentina, Chile, Netherlands, Philippines, South Korea, United States
Collaborators--

Timeline

Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 22, 2010
Enrollment StartJun 1, 2010
Primary CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 16.0 years ago

Interventions

Fluticasone furoate/Vilanterol Inhalation Powderdrug

Fluticasone furoate/Vilanterol Inhalation Powder inhaled orally once daily for 24 weeks

Fluticasone propionate/salmeterol Inhalation Powderdrug

Fluticasone propionate/salmeterol Inhalation Powder inhaled orally twice daily for 24 weeks

Placebo (1)drug

Inhalation powder inhaled orally once daily for 24 weeks

Placebo (2)drug

Inhalation powder inhaled orally twice daily for 24 weeks